ORPHELIA Pharma, a French company specialized in the development and commercialization of pediatric medicines, today announced that initiative Octalfa joined the company as a minority shareholder, director and operating partner.
Continue readingTargeOn SAS to become ORPHELIA Pharma SA
TargeOn SAS, a French company specialized in the development and commercialization of pediatric medicines, today announced that the company will be renamed ORPHELIA Pharma SA, effective October 9th, 2015.
Continue reading